Additionally, intranasal administration of the B1 receptor antagonist increased the amyloid plaque burden and accumulation of microglia in the cortex of mice in an AD model, indicating that bradykinin has a role in neuroinflammatory diseases (Asraf et al., 2017). This evidence concerns the gene KNG1 and Alzheimer disease.